Schedule 13G ownership disclosure

Xenon Pharmaceuticals Inc

Security class unavailable · CUSIP: 98420N105

Event date: 2014-11-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-16-001338
Form type
SC 13G
Filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK
CIK 818686
Filed
Mar 30, 2016
Reporting period
Nov 10, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub